This week on "The Top Line," we discuss 2022’s Fiercest Women in Life Science honorees. Each year, we spotlight women who are leading the way in life sciences—women who stand out as leaders, innovators and mentors. We’ll hear from Andrea Park and Querida Anderson on what it took to make the cut for this year's class of fiercest women in life sciences. Plus, this week's headlines. 

To learn more about topics in this episode:
2022's Fiercest Women in Life Sciences
Eli Lilly issues rare apology as fake Twitter Blue account proclaims free insulin for all
Eli Lilly pulls Twitter ads after blue check fallout: report
Roche's anti-amyloid antibody gantenerumab fails phase 3 in major blow to Alzheimer's ambitions
NFL expands head injury research project using impact-tracking mouthguards, as concussion protocols come under fire
Mayo Clinic launches digital referee for spotting potential bias in healthcare AI programs
Four decades in, ImmunoGen gets landmark green light in advanced ovarian cancer
Sanofi, GSK crash the COVID-19 vaccine party late with a world-first nod for their next-gen booster

"The Top Line" is produced by senior multimedia producer Teresa Carey with managing editor Querida Anderson and senior editors Annalee Armstrong, Ben Adams, Conor Hale and Eric Sagonowsky. The sound engineer is Caleb Hodgson. The stories are by all our “Fierce” journalists. Like and subscribe wherever you listen to your podcasts.

This week on "The Top Line," we discuss 2022’s Fiercest Women in Life Science honorees. Each year, we spotlight women who are leading the way in life sciences—women who stand out as leaders, innovators and mentors. We’ll hear from Andrea Park and Querida Anderson on what it took to make the cut for this year's class of fiercest women in life sciences. Plus, this week's headlines. 
To learn more about topics in this episode:
<ul>
<li><a href="https://www.fiercepharma.com/special-reports/2022s-fiercest-women-life-sciences">2022's Fiercest Women in Life Sciences</a></li>
<li><a href="https://www.fiercepharma.com/marketing/eli-lilly-hit-new-twitter-blue-fake-account-forced-apologize-over-free-insulin-tweet">Eli Lilly issues rare apology as fake Twitter Blue account proclaims free insulin for all</a></li>
<li><a href="https://www.fiercepharma.com/marketing/eli-lilly-pulls-twitter-ads-after-blue-check-fallout-report">Eli Lilly pulls Twitter ads after blue check fallout: report</a></li>
<li><a href="https://www.fiercebiotech.com/biotech/roches-anti-amyloid-antibody-gantenerumab-fails-phase-3-alzheimers-trials">Roche's anti-amyloid antibody gantenerumab fails phase 3 in major blow to Alzheimer's ambitions</a></li>
<li><a href="https://www.fiercebiotech.com/medtech/nfl-expands-head-injury-research-project-using-impact-tracking-mouthguards-concussion#:~:text=MedTech-,NFL%20expands%20head%20injury%20research%20project%20using%20impact%2Dtracking%20mouthguards,concussion%20protocols%20come%20under%20fire&amp;text=The%20National%20Football%20League%20aims,NCAA%20players%20from%20participating%20universities">NFL expands head injury research project using impact-tracking mouthguards, as concussion protocols come under fire</a></li>
<li><a href="https://www.fiercebiotech.com/medtech/mayo-clinic-launches-digital-referee-spotting-potential-bias-healthcare-ai-programs">Mayo Clinic launches digital referee for spotting potential bias in healthcare AI programs</a></li>
<li><a href="https://www.fiercepharma.com/pharma/four-decades-immunogen-gets-landmark-green-light-advanced-ovarian-cancer">Four decades in, ImmunoGen gets landmark green light in advanced ovarian cancer</a></li>
<li><a href="https://www.fiercepharma.com/pharma/sanofi-and-gsk-crash-covid-19-vaccine-late-world-first-nod-next-gen-booster-vidprevtyn-beta">Sanofi, GSK crash the COVID-19 vaccine party late with a world-first nod for their next-gen booster</a></li>
</ul>
"The Top Line" is produced by senior multimedia producer Teresa Carey with managing editor Querida Anderson and senior editors Annalee Armstrong, Ben Adams, Conor Hale and Eric Sagonowsky. The sound engineer is Caleb Hodgson. The stories are by all our “Fierce” journalists. Like and subscribe wherever you listen to your podcasts.

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning. 

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&amp;D and device development. Available every Friday morning.&nbsp;

The Top Line

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech and Fierce Pharma recount the latest industry trends and why they matter. We’ll analyze the week’s biggest business news—from mergers and marketing to drug R&D and device development. Available every Friday morning.

 

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech and Fierce Pharma recount the latest industry trends and why they matter. We&rsquo;ll analyze the week&rsquo;s biggest business news&mdash;from mergers and marketing to drug R&amp;D and device development. Available every Friday morning.
&nbsp;

Advertisement